Autres langues Quest Diagnostics Incorporated

Actions

DGX

US74834L1008

Installations et services en soins de santé

Marché Fermé - NYSE 22:04:17 17/09/2026			Varia. 5j.	Varia. 1 janv.
247,45 ^USD	+0,15%		+7,06%	+42,60%

15/09	Transcript : Quest Diagnostics Incorporated Presents at 2026 Global Healthcare Conference, Sep-15-2026 10:50 AM
14/09	Transcript : Quest Diagnostics Incorporated Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 10:00 AM

Autres langues

16/09	Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics
09/09	Quest Diagnostics Announces Apple Health App Users to Be Able to Order Labs from Quest Diagnostics
09/09	Apple Health app Users to be Able to Order Labs from Quest Diagnostics
03/09	Quest Diagnostics Insider Sold Shares Worth $2,427,200, According to a Recent SEC Filing
01/09	Renalytix plc and Quest Diagnostics Enter Agreement to Expand Kidneyintelx.Dkd Testing in the United States
31/08	GoodLife Health Bundles Quarterly ApoB Testing Into $299 Membership
25/08	Humanity Health Inc. And Quest Diagnostics Announce Availability Of Humanity Biological Age Analysis Through questhealth.com
25/08	Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference
25/08	Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com
24/08	Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio
24/08	Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
24/08	Quest Diagnostics Announces Addition of FDA-Cleared Elecsys Ptau217 Test and Launches New Multi-Biomarker Ad-Detect Blood Test
24/08	FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
24/08	Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance
24/08	Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology
12/08	Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6
12/08	Quest Diagnostics Declares Quarterly Cash Dividend
12/08	Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on October 21, 2026
30/07	Labcorp raises annual profit forecast on strong testing demand
30/07	Labcorp raises annual profit forecast on strong testing demand
30/07	Quest Diagnostics And Hologic, Inc. Conduct National Health Trends Study On Bacterial Vaginosis And STI Co-Infection
30/07	Labcorp raises annual profit forecast on strong testing demand
30/07	Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics
23/07	Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.
23/07	Quest Diagnostics Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026